Oncotarget
Evaluation of Ruxolitinib, a Janus Kinase Inhibitor, in Multiple Myeloma
February 07, 2024
BUFFALO, NY- February 7, 2024 A new #research p
Oncotarget is a primarily oncology-focused, peer-…
Visit Podcast Website
RSS Podcast Feed
Subscribe
Share
Add to MyCast